E2F2 Antikörper (C-Term)
-
- Target Alle E2F2 Antikörper anzeigen
- E2F2 (E2F Transcription Factor 2 (E2F2))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser E2F2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Antigen affinity
- Immunogen
- An amino acid sequence from the C-terminus of human E2F transcription factor 2 (ISDLFDSYDLGDLLIN) was used as the immunogen for this E2F2 antibody (100% mouse homology).
- Isotyp
- IgG
- Top Product
- Discover our top product E2F2 Primärantikörper
-
-
- Applikationshinweise
- The stated application concentrations are suggested starting amounts. Titration of the E2F2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 0.5-1 μg/mL
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
- Lagerung
- -20 °C
- Informationen zur Lagerung
- After reconstitution, the E2F2 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
-
- Target
- E2F2 (E2F Transcription Factor 2 (E2F2))
- Andere Bezeichnung
- E2F2 (E2F2 Produkte)
- Synonyme
- E2F-2 antikoerper, CG1071 antikoerper, Dmel\\CG1071 antikoerper, E2F antikoerper, E2F2 antikoerper, dE2F-2 antikoerper, dE2F2 antikoerper, dE2f2 antikoerper, de2f2 antikoerper, e2f2 antikoerper, 9230110J10 antikoerper, E130207A07 antikoerper, fb40b03 antikoerper, wu:fb40b03 antikoerper, E2F transcription factor 2 antikoerper, si:ch211-160f23.5 antikoerper, E2F2 antikoerper, E2f2 antikoerper, si:ch211-160f23.5 antikoerper
- Hintergrund
- E2F transcription factor 2, also called E2F-2, is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The gene is mapped to 1p36 by fluorescence in situ hybridization. Electrophoretic mobility shift assays revealed the specific binding of E2F2 to ECE1b promoter sequences containing either allele of the C-338A polymorphism, with the -338A allele being associated with an increased affinity to E2F2 compared with -338C. The ability of Myc to induce S phase was impaired in the absence of either E2f2 or E2f3 but not E2f1 or E2f4. In contrast, the ability of Myc to induce apoptosis was markedly reduced in cells deleted for E2f1 but not E2f2 or E2f3.
- UniProt
- Q14209
- Pathways
- Zellzyklus, Mitotic G1-G1/S Phases, DNA Replication
-